Introduction of Typhoid Conjugate Vaccines in Africa and Asia

Seroefficacy of Vi Polysaccharide–Tetanus Toxoid Typhoid Conjugate Vaccine (Typbar TCV)

(2018) Merryn Voysey et al.   CLINICAL INFECTIOUS DISEASES

Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial

(2017) Celina Jin et al.   LANCET

The STRATAA study protocol: a programme to assess the burden of enteric fever in Bangladesh, Malawi and Nepal using prospective population census, passive surveillance, serological studies and healthcare utilisation surveys

(2017) Thomas C Darton et al.   BMJ Open

The burden of typhoid fever in low- and middle-income countries: A meta-regression approach

(2017) Marina Antillón et al.   PLoS Neglected Tropical Diseases

Lessons learnt from human papillomavirus (HPV) vaccination in 45 low- and middle-income countries

(2017) Katherine E. Gallagher et al.   PLoS One

Safety and Immunogenicity of a Vi Polysaccharide–Tetanus Toxoid Conjugate Vaccine (Typbar-TCV) in Healthy Infants, Children, and Adults in Typhoid Endemic Areas: A Multicenter, 2-Cohort, Open-Label, Double-Blind, Randomized Controlled Phase 3 Study

(2015) Vadrevu Krishna Mohan et al.   CLINICAL INFECTIOUS DISEASES

Rapid Emergence of Multidrug Resistant, H58-Lineage Salmonella Typhi in Blantyre, Malawi

(2015) Nicholas A. Feasey et al.   PLoS Neglected Tropical Diseases

A policy framework for accelerating adoption of new vaccines

(2011) Orin S. Levine et al.   Human vaccines & immunotherapeutics